Found: 9
Select item for more details and to access through your institution.
Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective Study.
- Published in:
- Biomedicines, 2021, v. 9, n. 8, p. 972, doi. 10.3390/biomedicines9080972
- By:
- Publication type:
- Article
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 326, doi. 10.1002/hon.2861
- By:
- Publication type:
- Article
Induction therapy in acute myeloid leukemia: Is it time to put aside standard 3 + 7?
- Published in:
- 2019
- By:
- Publication type:
- Journal Article
Current Therapeutic Results and Treatment Options for Older Patients with Relapsed Acute Myeloid Leukemia.
- Published in:
- Cancers, 2019, v. 11, n. 2, p. 224, doi. 10.3390/cancers11020224
- By:
- Publication type:
- Article
Bendamustine-Bortezomib-Dexamethasone in Heavily Pretreated Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S254, doi. 10.1016/j.clml.2018.07.158
- By:
- Publication type:
- Article
Acute immune toxicity during anti-thymocyte globulin: That's CARPA!
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. E22, doi. 10.1002/ajh.24945
- By:
- Publication type:
- Article
Bendamustine-Bortezomib-Dexametasone (BVD) in the Management of Relapsed and Refractory Multiple Myeloma: A Real-Life Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S343, doi. 10.1016/j.clml.2017.07.163
- By:
- Publication type:
- Article
Bendamustine-Bortezomib-Dexamethasone (BVD) in the Management of Relapsed and Refractory Multiple Myeloma: A Real-Life Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e60, doi. 10.1016/j.clml.2017.03.111
- By:
- Publication type:
- Article
Natural killer expansion, human leukocyte antigens- E expression and CD14<sup>+</sup> CD56<sup>+</sup> monocytes in a myelodysplastic syndrome patient.
- Published in:
- European Journal of Haematology, 2013, v. 91, n. 3, p. 265, doi. 10.1111/ejh.12152
- By:
- Publication type:
- Article